Arava
leflunomide
- Strength
- 20 mg/1
- Form
- Tablet, Film Coated
- Class
- Antirheumatic Agent
sanofi-aventis U.S. LLC
Listed by Burel Pharmaceuticals, LLC
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Antirheumatic Agent |
| Approval route | ANDA — approved generic |
| NDC code | 35573-447 |
| FDA application | ANDA213497 |
| RxNorm concept | 205284 |
| Package sizes listed | 1 |
| Marketed since | January 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
leflunomide
sanofi-aventis U.S. LLC
leflunomide
sanofi-aventis U.S. LLC
leflunomide
sanofi-aventis U.S. LLC
Alembic Pharmaceuticals Inc.
Zydus Lifesciences Limited
AvPAK
NuCare Pharmaceuticals, Inc.
Zydus Pharmaceuticals (USA) Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.